カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の抗不安剤市場2022年：特許医薬品、ジェネリック医薬品、その他

◆英語タイトル：Global Anti-Anxiety Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8731）◆商品コード：GIR22MY8731
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：98
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

抗不安剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗不安剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗不安剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・特許医薬品、ジェネリック医薬品、その他

用途別セグメントは次のように区分されます。
・不安解消、睡眠改善、早漏防止、その他

世界の抗不安剤市場の主要な市場プレーヤーは以下のとおりです。
・HUAHAI PHARMACEUTICAL、KANGHONG PHARMACEUTICAL、Eli Lilly And Company、Win Sunny、Gsk、JIANFENG Pharmaceutical、APOTEX、Mylan、Zydus Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗不安剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗不安剤メーカーの企業概要、2019年～2022年までの抗不安剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗不安剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗不安剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗不安剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗不安剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗不安剤の産業チェーンを掲載しています。
・第13、14、15章では、抗不安剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：HUAHAI PHARMACEUTICAL、KANGHONG PHARMACEUTICAL、Eli Lilly And Company、Win Sunny、Gsk、JIANFENG Pharmaceutical、APOTEX、Mylan、Zydus Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：特許医薬品、ジェネリック医薬品、その他
・用途別分析2017年-2028年：不安解消、睡眠改善、早漏防止、その他
・抗不安剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・抗不安剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・抗不安剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・抗不安剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・抗不安剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Anti-Anxiety Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti-Anxiety Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Treat anxiety accounting for % of the Anti-Anxiety Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Patent Medicine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-Anxiety Drugs include HUAHAI PHARMACEUTICAL, KANGHONG PHARMACEUTICAL, Eli Lilly And Company, Win Sunny, and Gsk, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-Anxiety Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Patent Medicine
Generic Drugs
Others
Market segment by Application can be divided into
Treat anxiety
Help Sleep
Treat Premature Ejaculation
Others
The key market players for global Anti-Anxiety Drugs market are listed below:
HUAHAI PHARMACEUTICAL
KANGHONG PHARMACEUTICAL
Eli Lilly And Company
Win Sunny
Gsk
JIANFENG Pharmaceutical
APOTEX
Mylan
Zydus Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Anxiety Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Anxiety Drugs, with price, sales, revenue and global market share of Anti-Anxiety Drugs from 2019 to 2022.
Chapter 3, the Anti-Anxiety Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Anxiety Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-Anxiety Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-Anxiety Drugs.
Chapter 13, 14, and 15, to describe Anti-Anxiety Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Anti-Anxiety Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Anxiety Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Patent Medicine
1.2.3 Generic Drugs
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Anxiety Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Treat anxiety
1.3.3 Help Sleep
1.3.4 Treat Premature Ejaculation
1.3.5 Others
1.4 Global Anti-Anxiety Drugs Market Size & Forecast
1.4.1 Global Anti-Anxiety Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-Anxiety Drugs Sales in Volume (2017-2028)
1.4.3 Global Anti-Anxiety Drugs Price (2017-2028)
1.5 Global Anti-Anxiety Drugs Production Capacity Analysis
1.5.1 Global Anti-Anxiety Drugs Total Production Capacity (2017-2028)
1.5.2 Global Anti-Anxiety Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Anxiety Drugs Market Drivers
1.6.2 Anti-Anxiety Drugs Market Restraints
1.6.3 Anti-Anxiety Drugs Trends Analysis
2 Manufacturers Profiles
2.1 HUAHAI PHARMACEUTICAL
2.1.1 HUAHAI PHARMACEUTICAL Details
2.1.2 HUAHAI PHARMACEUTICAL Major Business
2.1.3 HUAHAI PHARMACEUTICAL Anti-Anxiety Drugs Product and Services
2.1.4 HUAHAI PHARMACEUTICAL Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 KANGHONG PHARMACEUTICAL
2.2.1 KANGHONG PHARMACEUTICAL Details
2.2.2 KANGHONG PHARMACEUTICAL Major Business
2.2.3 KANGHONG PHARMACEUTICAL Anti-Anxiety Drugs Product and Services
2.2.4 KANGHONG PHARMACEUTICAL Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Eli Lilly And Company
2.3.1 Eli Lilly And Company Details
2.3.2 Eli Lilly And Company Major Business
2.3.3 Eli Lilly And Company Anti-Anxiety Drugs Product and Services
2.3.4 Eli Lilly And Company Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Win Sunny
2.4.1 Win Sunny Details
2.4.2 Win Sunny Major Business
2.4.3 Win Sunny Anti-Anxiety Drugs Product and Services
2.4.4 Win Sunny Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Gsk
2.5.1 Gsk Details
2.5.2 Gsk Major Business
2.5.3 Gsk Anti-Anxiety Drugs Product and Services
2.5.4 Gsk Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 JIANFENG Pharmaceutical
2.6.1 JIANFENG Pharmaceutical Details
2.6.2 JIANFENG Pharmaceutical Major Business
2.6.3 JIANFENG Pharmaceutical Anti-Anxiety Drugs Product and Services
2.6.4 JIANFENG Pharmaceutical Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 APOTEX
2.7.1 APOTEX Details
2.7.2 APOTEX Major Business
2.7.3 APOTEX Anti-Anxiety Drugs Product and Services
2.7.4 APOTEX Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Anti-Anxiety Drugs Product and Services
2.8.4 Mylan Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Zydus Pharmaceutical
2.9.1 Zydus Pharmaceutical Details
2.9.2 Zydus Pharmaceutical Major Business
2.9.3 Zydus Pharmaceutical Anti-Anxiety Drugs Product and Services
2.9.4 Zydus Pharmaceutical Anti-Anxiety Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-Anxiety Drugs Breakdown Data by Manufacturer
3.1 Global Anti-Anxiety Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-Anxiety Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-Anxiety Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Anxiety Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-Anxiety Drugs Manufacturer Market Share in 2021
3.5 Global Anti-Anxiety Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-Anxiety Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Anxiety Drugs Market Size by Region
4.1.1 Global Anti-Anxiety Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-Anxiety Drugs Revenue by Region (2017-2028)
4.2 North America Anti-Anxiety Drugs Revenue (2017-2028)
4.3 Europe Anti-Anxiety Drugs Revenue (2017-2028)
4.4 Asia-Pacific Anti-Anxiety Drugs Revenue (2017-2028)
4.5 South America Anti-Anxiety Drugs Revenue (2017-2028)
4.6 Middle East and Africa Anti-Anxiety Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-Anxiety Drugs Sales in Volume by Type (2017-2028)
5.2 Global Anti-Anxiety Drugs Revenue by Type (2017-2028)
5.3 Global Anti-Anxiety Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-Anxiety Drugs Sales in Volume by Application (2017-2028)
6.2 Global Anti-Anxiety Drugs Revenue by Application (2017-2028)
6.3 Global Anti-Anxiety Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Anxiety Drugs Sales by Type (2017-2028)
7.2 North America Anti-Anxiety Drugs Sales by Application (2017-2028)
7.3 North America Anti-Anxiety Drugs Market Size by Country
7.3.1 North America Anti-Anxiety Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-Anxiety Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Anxiety Drugs Sales by Type (2017-2028)
8.2 Europe Anti-Anxiety Drugs Sales by Application (2017-2028)
8.3 Europe Anti-Anxiety Drugs Market Size by Country
8.3.1 Europe Anti-Anxiety Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-Anxiety Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-Anxiety Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-Anxiety Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-Anxiety Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-Anxiety Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-Anxiety Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-Anxiety Drugs Sales by Type (2017-2028)
10.2 South America Anti-Anxiety Drugs Sales by Application (2017-2028)
10.3 South America Anti-Anxiety Drugs Market Size by Country
10.3.1 South America Anti-Anxiety Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-Anxiety Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Anxiety Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-Anxiety Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-Anxiety Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-Anxiety Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-Anxiety Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-Anxiety Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-Anxiety Drugs
12.3 Anti-Anxiety Drugs Production Process
12.4 Anti-Anxiety Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-Anxiety Drugs Typical Distributors
13.3 Anti-Anxiety Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Anti-Anxiety Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti-Anxiety Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. HUAHAI PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 4. HUAHAI PHARMACEUTICAL Major Business
Table 5. HUAHAI PHARMACEUTICAL Anti-Anxiety Drugs Product and Services
Table 6. HUAHAI PHARMACEUTICAL Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. KANGHONG PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 8. KANGHONG PHARMACEUTICAL Major Business
Table 9. KANGHONG PHARMACEUTICAL Anti-Anxiety Drugs Product and Services
Table 10. KANGHONG PHARMACEUTICAL Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Eli Lilly And Company Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly And Company Major Business
Table 13. Eli Lilly And Company Anti-Anxiety Drugs Product and Services
Table 14. Eli Lilly And Company Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Win Sunny Basic Information, Manufacturing Base and Competitors
Table 16. Win Sunny Major Business
Table 17. Win Sunny Anti-Anxiety Drugs Product and Services
Table 18. Win Sunny Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Gsk Basic Information, Manufacturing Base and Competitors
Table 20. Gsk Major Business
Table 21. Gsk Anti-Anxiety Drugs Product and Services
Table 22. Gsk Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. JIANFENG Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. JIANFENG Pharmaceutical Major Business
Table 25. JIANFENG Pharmaceutical Anti-Anxiety Drugs Product and Services
Table 26. JIANFENG Pharmaceutical Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. APOTEX Basic Information, Manufacturing Base and Competitors
Table 28. APOTEX Major Business
Table 29. APOTEX Anti-Anxiety Drugs Product and Services
Table 30. APOTEX Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Anti-Anxiety Drugs Product and Services
Table 34. Mylan Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Zydus Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Zydus Pharmaceutical Major Business
Table 37. Zydus Pharmaceutical Anti-Anxiety Drugs Product and Services
Table 38. Zydus Pharmaceutical Anti-Anxiety Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Anti-Anxiety Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Anti-Anxiety Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Anti-Anxiety Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Anti-Anxiety Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Anti-Anxiety Drugs Production Site of Key Manufacturer
Table 44. Anti-Anxiety Drugs New Entrant and Capacity Expansion Plans
Table 45. Anti-Anxiety Drugs Mergers & Acquisitions in the Past Five Years
Table 46. Global Anti-Anxiety Drugs Sales by Region (2017-2022) & (K Units)
Table 47. Global Anti-Anxiety Drugs Sales by Region (2023-2028) & (K Units)
Table 48. Global Anti-Anxiety Drugs Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Anti-Anxiety Drugs Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Anti-Anxiety Drugs Sales by Type (2017-2022) & (K Units)
Table 51. Global Anti-Anxiety Drugs Sales by Type (2023-2028) & (K Units)
Table 52. Global Anti-Anxiety Drugs Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Anti-Anxiety Drugs Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Anti-Anxiety Drugs Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Anti-Anxiety Drugs Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Anti-Anxiety Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Global Anti-Anxiety Drugs Sales by Application (2023-2028) & (K Units)
Table 58. Global Anti-Anxiety Drugs Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Anti-Anxiety Drugs Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Anti-Anxiety Drugs Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Anti-Anxiety Drugs Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Anti-Anxiety Drugs Sales by Country (2017-2022) & (K Units)
Table 63. North America Anti-Anxiety Drugs Sales by Country (2023-2028) & (K Units)
Table 64. North America Anti-Anxiety Drugs Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Anti-Anxiety Drugs Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Anti-Anxiety Drugs Sales by Type (2017-2022) & (K Units)
Table 67. North America Anti-Anxiety Drugs Sales by Type (2023-2028) & (K Units)
Table 68. North America Anti-Anxiety Drugs Sales by Application (2017-2022) & (K Units)
Table 69. North America Anti-Anxiety Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Europe Anti-Anxiety Drugs Sales by Country (2017-2022) & (K Units)
Table 71. Europe Anti-Anxiety Drugs Sales by Country (2023-2028) & (K Units)
Table 72. Europe Anti-Anxiety Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Anti-Anxiety Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Anti-Anxiety Drugs Sales by Type (2017-2022) & (K Units)
Table 75. Europe Anti-Anxiety Drugs Sales by Type (2023-2028) & (K Units)
Table 76. Europe Anti-Anxiety Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Europe Anti-Anxiety Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Anti-Anxiety Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Anti-Anxiety Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Anti-Anxiety Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Anti-Anxiety Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Anti-Anxiety Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Anti-Anxiety Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Anti-Anxiety Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Anti-Anxiety Drugs Sales by Application (2023-2028) & (K Units)
Table 86. South America Anti-Anxiety Drugs Sales by Country (2017-2022) & (K Units)
Table 87. South America Anti-Anxiety Drugs Sales by Country (2023-2028) & (K Units)
Table 88. South America Anti-Anxiety Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Anti-Anxiety Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Anti-Anxiety Drugs Sales by Type (2017-2022) & (K Units)
Table 91. South America Anti-Anxiety Drugs Sales by Type (2023-2028) & (K Units)
Table 92. South America Anti-Anxiety Drugs Sales by Application (2017-2022) & (K Units)
Table 93. South America Anti-Anxiety Drugs Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Anti-Anxiety Drugs Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Anti-Anxiety Drugs Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Anti-Anxiety Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Anti-Anxiety Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Anti-Anxiety Drugs Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Anti-Anxiety Drugs Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Anti-Anxiety Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Anti-Anxiety Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Anti-Anxiety Drugs Raw Material
Table 103. Key Manufacturers of Anti-Anxiety Drugs Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Anti-Anxiety Drugs Typical Distributors
Table 107. Anti-Anxiety Drugs Typical Customers
List of Figures
Figure 1. Anti-Anxiety Drugs Picture
Figure 2. Global Anti-Anxiety Drugs Revenue Market Share by Type in 2021
Figure 3. Patent Medicine
Figure 4. Generic Drugs
Figure 5. Others
Figure 6. Global Anti-Anxiety Drugs Revenue Market Share by Application in 2021
Figure 7. Treat anxiety
Figure 8. Help Sleep
Figure 9. Treat Premature Ejaculation
Figure 10. Others
Figure 11. Global Anti-Anxiety Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Anti-Anxiety Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Anti-Anxiety Drugs Sales (2017-2028) & (K Units)
Figure 14. Global Anti-Anxiety Drugs Price (2017-2028) & (US$/Unit)
Figure 15. Global Anti-Anxiety Drugs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Anti-Anxiety Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Anti-Anxiety Drugs Market Drivers
Figure 18. Anti-Anxiety Drugs Market Restraints
Figure 19. Anti-Anxiety Drugs Market Trends
Figure 20. Global Anti-Anxiety Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Anti-Anxiety Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Anti-Anxiety Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Anti-Anxiety Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Anti-Anxiety Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Anti-Anxiety Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Anti-Anxiety Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Anti-Anxiety Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Anti-Anxiety Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Anti-Anxiety Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Anti-Anxiety Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Anti-Anxiety Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Anti-Anxiety Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Anti-Anxiety Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Anti-Anxiety Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Anti-Anxiety Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Anti-Anxiety Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Anti-Anxiety Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Anti-Anxiety Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Anti-Anxiety Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Anti-Anxiety Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Anti-Anxiety Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Anti-Anxiety Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Anti-Anxiety Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Anti-Anxiety Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Anti-Anxiety Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Anti-Anxiety Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Anti-Anxiety Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Anti-Anxiety Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Anti-Anxiety Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Anti-Anxiety Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Anti-Anxiety Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Anti-Anxiety Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Anti-Anxiety Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Anti-Anxiety Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Anti-Anxiety Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Anti-Anxiety Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Anti-Anxiety Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Anti-Anxiety Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Anti-Anxiety Drugs in 2021
Figure 79. Manufacturing Process Analysis of Anti-Anxiety Drugs
Figure 80. Anti-Anxiety Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の抗不安剤市場2022年：特許医薬品、ジェネリック医薬品、その他(Global Anti-Anxiety Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • プレガバリン経口液のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • 世界の不安障害・パニック障害治療薬市場2022年：抗うつ薬、抗不安薬
  • 世界の抗肥満治療薬市場2022年：末梢性抗肥満薬、中枢性抗肥満薬
  • 世界のセルトラリン塩酸塩錠市場2022年：ジェネリック医薬品、特許薬、その他
  • 世界の動物用感染症治療薬市場2022年：抗菌剤、抗ウイルス剤、抗真菌剤、その他